NLM Digital Collections

Search

Start Over Subjects Narcotic Antagonists -- therapeutic use ✖Remove constraint Subjects: Narcotic Antagonists -- therapeutic use

1. The integration of harm reduction and healthcare: implications and lessons for healthcare reform

Author(s):
Schafer, Peter, author
Calvo, Michele, author
Publication:
New York, N.Y. : New York Academy of Medicine, June 2015
Subject(s):
Behavioral Medicine -- organization & administration
Community Health Services -- organization & administration
Delivery of Health Care, Integrated -- organization & administration
Harm Reduction
Patient-Centered Care
Primary Health Care -- organization & administration
Analgesics, Opioid -- poisoning
Drug Overdose -- drug therapy
Health Care Reform
Health Policy
Health Services Accessibility
Health Services Needs and Demand
Interprofessional Relations
Medically Underserved Area
Naloxone -- therapeutic use
Narcotic Antagonists -- therapeutic use
Opioid-Related Disorders -- drug therapy
Organizational Case Studies
Patient Acceptance of Health Care
Poverty Areas
Professional Practice Location
Quality of Health Care
Social Determinants of Health
Substance Abuse, Intravenous
Substance-Related Disorders -- therapy
Syringes
Humans
New York
United States

2. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 3, 2018
Subject(s):
Analgesics, Opioid -- therapeutic use
Narcotic Antagonists -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Buprenorphine, Naloxone Drug Combination -- therapeutic use
Cost-Benefit Analysis
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Treatment Outcome
Humans
United States